Project Grant R01EY038196
- Federal Project Grant Award Summary The National Eye Institute (NEI), under its Vision Research program (CFDA 93.867), awarded $1,703,489 to President and Fellows of Harvard College/Harvard Medical School (awarded September 15, 2025; completion date January 31, 2029) to conduct integrated research on the neural and computational mechanisms underlying preferential viewing behavior in primates. The project will deliver research products including empirical findings on how visual preferences are...
- Federal Grant Award Summary The National Eye Institute (NEI) awarded Harvard Medical School a $464,750 Project Grant under the Vision Research program (CFDA 93.867) effective September 1, 2025, through August 31, 2027. This award funds research to understand how lineage contributes to cell diversity in the chicken retina, including the high acuity area. The primary research product will be reconstructed multi-generational lineage trees that identify intra-clonal relationships and generate models...
- Federal Project Grant Award Summary The National Eye Institute (NEI) awarded Harvard Medical School $134,545 under the Vision Research program (CFDA 93.867) for a two-year project grant running from April 1, 2026 through March 31, 2028. This award supports Dr. Lujing Chen's research into neuronal and vascular interactions in the visual system, with the ultimate objective of developing clinical insights to improve treatments for vision loss in related diseases. The research will establish...
- Federal Project Grant Award Summary The National Eye Institute (NEI) awarded The Schepens Eye Research Institute, Inc. a Project Grant of $545,948 under the Vision Research program (CFDA 93.867) to advance understanding of glaucoma pathophysiology. The award, effective April 1, 2026 through March 31, 2030, supports research investigating the role of reactive astrocytes in glaucoma progression and retinal ganglion cell (RGC) survival. The research aims to move beyond traditional neurocentric...
- This federal Project Grant award of $576,474.00 was provided by the National Eye Institute (NEI), which administers the Vision Research federal grant program (CFDA 93.867). The award supports a research project titled "Hierarchy of Visuospatial Codes in the Primate Temporal Lobe" conducted by President and Fellows of Harvard College, doing business as Harvard Medical School. The project aims to elucidate the relationship between visual feature processing in the inferior temporal cortex...
- Federal Grant Award Summary Boston Children's Hospital received a $136,512 Project Grant from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) effective July 1, 2025, through June 30, 2027. The award supports research investigating how intrinsically photosensitive retinal ganglion cells (ipRGCs) transform light information in melanopsin pathways to regulate physiological and behavioral responses. The research employs advanced imaging techniques to measure...
- Federal Project Grant Award Summary The National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), awarded Trustees of Boston University a $966,655 Project Grant effective August 1, 2025, through February 28, 2030, to develop and test a dynamic spatiotemporal normalization framework for human vision. The primary products of this award include high-quality behavioral and functional magnetic resonance imaging (fMRI) datasets that characterize how human perception integrates...
- Federal Project Grant Award Summary The National Eye Institute (NEI) awarded $173,016 to the Whitehead Institute for Biomedical Research under the Vision Research program (CFDA 93.867) for a project grant effective August 1, 2025, through July 31, 2027. This award supports systematic identification and mechanistic characterization of novel oxidative protective genes to prevent retinal pigment epithelium (RPE) degeneration in age-related macular degeneration (AMD). The research involves...
- Federal Grant Award Summary Massachusetts General Hospital received a $453,750 Project Grant from the National Eye Institute (NEI) Vision Research program (CFDA 93.867), awarded September 1, 2025, with completion targeted for August 31, 2027. The project, titled "Finessing the Details: Subclasses of LGN Neurons and the Richness of Spatial Transcriptomics," applies spatial transcriptomics technologies to map the spatial distribution and genetic characteristics of neuronal cell types...
- Federal Grant Award Summary Baylor College of Medicine received a $646,167 Project Grant from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867), effective April 1, 2026 through March 31, 2031. The award funds investigations into the cellular and molecular mechanisms underlying Age-Related Macular Degeneration (AMD), the leading cause of vision loss in elderly populations. The research applies high-throughput functional genomics approaches to identify causal...
Award Details: The National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), awarded a Project Grant of $802,355 to President and Fellows of Harvard College (operating as Harvard Medical School) beginning May 1, 2026 and extending through February 28, 2030. The research is being conducted at the institution's Boston, Massachusetts facilities. Research Products and Deliverables: This award funds fundamental neuroscience research investigating how experience-dependent glucocorticoid receptor (GR) signaling in astrocytes regulates visual system development and plasticity during critical periods. The primary deliverables include: (1) characterization of astrocyte GR signaling effects on postnatal visual circuit development in the mouse primary visual cortex; (2) determination of astrocyte GR signaling's contribution to proper visual critical period timing; and (3) elucidation of the molecular mechanisms by which astrocyte GR signaling drives visual circuit maturation, including perineuronal net formation. The research aims to advance understanding of critical period regulation and non-neuronal cell contributions to visual system development, with potential applications for improving clinical treatment of amblyopia, a vision loss condition affecting 2–5% of the human population. Expected research products include empirical findings, molecular data, and mechanistic insights applicable to vision loss prevention and treatment strategies.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $802.4k | 4/17/26 |